Form 4: Emergent BioSolutions EVP Richard Lindahl Reports Stock Disposals for Tax Obligations

Richard S. Lindahl, EVP and CFO of Emergent BioSolutions, reported disposing of shares to cover tax obligations on February 29, 2024, and March 1, 2024.

Summary

• Richard S. Lindahl, the EVP and Chief Financial Officer of Emergent BioSolutions Inc., filed a Form 4 with the SEC.
• The report details the disposal of common stock to cover tax obligations.
• On February 29, 2024, 9,037 shares were disposed of at a price of $3.23 per share.
• On March 1, 2024, 684 shares were disposed of at a price of $3.39 per share.
• Following these transactions, Lindahl directly owns 158,742 shares of Emergent BioSolutions Inc.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock disposals for tax obligations, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock disposal may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates